pharmacodynamics Flashcards
Physiologic receptor mechanisms vs non-physiologic receptor mechanisms.
Physiologic mechanisms have an endogenous signal that a drug can mimic (agonist) or block (antagonist). Non-physiologic mechanisms do not have endogenous signals. Drugs operate by otherwise disrupting a physiologic process.
What is the difference between receptor and non-receptor mechanisms of drug action.
non-receptor mechanisms have direct physical or chemical effects on physiology (eg antacids that increase pH of stomach). Receptor mechanisms bind to endogenous receptors to induce or block effects.
What is the quantitative dose-response relationship for receptor binding (basic binding equation)?
([DR]/Rt)=([D]/[D]+Kd) where Kd is the ratio k2/k1 (rate of dissociation/rate of association).
Kd
the concentration of drug at which half of target receptors are bound. Analagous to Km in enzyme kinetics, a drug with a low Kd will have high affinity for receptor, and a drug with a high Kd will have a low affinity.
Potency
Kd in a dose-response plot. Response can be biochemical/ionic (2nd messenger at cellular level), physiologic (effect at level of tissue/organ), or integrated body response AS LONG AS IT IS CONTINUOUS.
Efficacy
The theoretical maximum effect that a drug can have (asymptote of continuous dose-response curve). Analagous to Vmax in enzyme kinetics.
What type of drugs effect can be overcome by increasing the concentration of the endogenous substance.
A competitive antagonist. They decrease potency of the endogenous substance (or another drug) (increase Km).
The effect of this type of drug cannot be overcome by increasing the amount of the endogenous substance.
Non-competitive antagonist. These decrease the efficacy (Vmax) without affecting the potency (Kd) of the endogenous substance or other drug.
Graded vs quantal studies.
Graded studies are done in vitro usually. They measure the effect of a drug on a specific tissue or receptor with a continuous response variable. Quantal studies use a dichotomous outcome on a population of individuals (or animals). Give different groups of animals different doses and then plot the cumulative proportion protected (y) vs the log dose (x). Note that quantal studies only measure potency (not efficacy).
Effective mean dose (ED50)
Dose at which the cumulative proportion of study participants with the outcome = 50%. It is analagous to Kd in graded response studies and is a measure of drug POTENCY.
Therapeutic index (safety margin)
TD50/ED50 where TD50= toxic dose OR LD50, lethal dose.
How can a difference in slopes of effective dose and lethal dose curves be interpreted?
It suggests that the mechanism by which a drug is lethal is different (different receptor target) than the principle drug effect.
When does drug receptor supersensitivity occur?
After chronic use of a receptor antagonist, more receptor or more endogenous agonist (or both) are typically produced. Once antagonist is stopped, pt is supersensitive to the agonist.
Tachyphylaxis
Stimulation of a receptor over time can produce a decreased response. If that response occurs in seconds to minutes, it is tachyphylaxis.
Tolerance
desensitization to a drug that takes hours to days to develop.